Webinar: Together We Can: ways you can get involved!
Together We Can: ways you can get involved!
Search
Search results
Ultra Challenges 2025
With 18 events to choose from in 2025, these hugely popular events are back for another year! Whether you run, jog or walk, you can support Retina UK's vital work whilst achieving an amazing personal goal. Join #TeamRetinaUK today!
Meet our Trustee: Professor John Marshall MBE
Prof John Marshall is the Frost Professor of Ophthalmology at the Institute of Ophthalmology at University College London.
Ultra Challenges 2025
With 18 events to choose from in 2025, these hugely popular events are back for another year! Whether you run, jog or walk, you can support Retina UK's vital work whilst achieving an amazing personal goal. Join #TeamRetinaUK today!
e-Newsletter – May 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Gene therapy shows promise in tackling X-linked RP
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
SB-007, we’ve been expecting you
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
Retinal transplantation studies
Several groups around the world are investigating the use of retinal transplantation in the treatment of inherited retinal diseases.
ReNeuron trial FAQs
You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.
Beware of online adverts about treatments
The Retina UK community is sometimes targeted by adverts online or in social media, offering invasive treatments for inherited sight loss.